Share Twitter LinkedIn Facebook Email Gareth Morgan, MD, from University of Arkansas for Medical Sciences discusses immunoactive treatments and bispecific antibodies, CAR-T cells, and monovalent antibodiesz at the 2017 American Society of Hematology.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read